CAS: 59831-65-1 - Halopemide

Formel: C₂₁H₂₂ClFN₄O₂

InChl: InChI=1/C21H22ClFN4O2/c22-15-3-6-19-18(13-15)25-21(29)27(19)17-7-10-26(11-8-17)12-9-24-20(28)14-1-4-16(23)5-2-14/h1-6,13,17H,7-12H2,(H,24,28)(H,25,29)

Synonyme:

• 59831-65-1
• N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-4-fluorobenzamide
• N-{2-[4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]ethyl}-4-fluorobenzamide

Halopemide

CAS: 59831-65-1

Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human …

• Formel: C₂₁H₂₂ClFN₄O₂
• Reinheit: 96.29%
• Farbe und Form: Solid
• Molekulargewicht: 416.88

Halopemide

CAS: 59831-65-1

Applications Halopemide acts as a small molecule inhibitor for phospholipase D (PLD), an important phosphlipid …

• Formel: C₂₁H₂₂ClFN₄O₂
• Farbe und Form: Neat
• Molekulargewicht: 416.876

N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide

CAS: 59831-65-1

N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide (NFA) is a novel benzodiazepine receptor inverse agonist that has been shown to be …

• Formel: C₂₁H₂₂ClFN₄O₂
• Reinheit: Min. 95%
• Molekulargewicht: 416.88 g/mol